<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products; Guidance for Industry; Availability</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products; Guidance for Industry; Availability</h1>
    <div class="metadata">Published: 2026-02-05 12:26:33</div>
    <div class="summary">The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products." The document provides guidance about the nonclinical information FDA recommends to support development and approval of orally inhaled nicotine-containing drug products, including electronic nicotine delivery systems intended for smoking cessation and related chronic indications. This guidance finalizes the draft guidance of the same name issued August 6, 2018.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2020/10/29/2020-23999/nonclinical-testing-of-orally-inhaled-nicotine-containing-drug-products-guidance-for-industry" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2020/10/29/2020-23999/nonclinical-testing-of-orally-inhaled-nicotine-containing-drug-products-guidance-for-industry</a></div>
</body>
</html>
